酪氨酸磷酸化抑制剂AG 835 T22450

Product Introduction
Bioactivity


英文名: Tyrphostin B44, (+) enantiomer

描述: Tyrphostin B44, (+) enantiomer 是一种表皮生长因子受体 (EGFR) 激酶抑制剂，IC50 为 0.86 μM，活性低于 (-) 对映体。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 60 mg/ml (194.6 mM)


关键字: non-metastatic tumors | INBL | antitumor | (+)-Tyrphostin B44 | Epidermal growth factor receptor | Tyrphostin B50 | ErbB-1 | Tyrphostin B-44, (+) enantiomer | Inhibitor | Tyrphostin B 50 | CALO | cervical carcinoma cell | EGFR | Tyrphostin B44, enantiomer | inhibit | Tyrphostin B44, (+) enantiomer | Tyrphostin AG835 | HER1 | Tyrphostin AG-835 | Tyrphostin AG 835 | Tyrphostin B-50

相关产品: Tyrosine kinase-IN-7 | EGFR/HER2/DHFR-IN-2 | EGFR-IN-90 | Ginsenoside Rh2 | AZ-5104 | Tyrphostin A9 | Pertuzumab | EGFR-IN-76 | Olmutinib | AZ7550 hydrochloride

相关库: Anti-Cancer Compound Library | Membrane Protein-targeted Compound Library | Anti-Lung Cancer Compound Library | Anti-Ovarian Cancer Compound Library | Kinase Inhibitor Library | Inhibitor Library | Anti-Colorectal Cancer Compound Library | Tyrosine Kinase Inhibitor Library | Reprogramming Compound Library | Bioactive Compound Library

酪氨酸磷酸化抑制剂AG 835 T22450信息由TargetMol中国为您提供，如您想了解更多关于酪氨酸磷酸化抑制剂AG 835 T22450报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途